Alzheimer's Disease News and Research RSS Feed - Alzheimer's Disease News and Research Twitter

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Research: MHCI protein moonlights in nervous system to regulate synapses

Research: MHCI protein moonlights in nervous system to regulate synapses

When it comes to the brain, "more is better" seems like an obvious assumption. But in the case of synapses, which are the connections between brain cells, too many or too few can both disrupt brain function. [More]
Renowned photographer creates 'Profiles of LBD' portrait series to support LBD campaign

Renowned photographer creates 'Profiles of LBD' portrait series to support LBD campaign

In honor of Lewy Body Dementia (LBD) Awareness Month, the Lewy Body Dementia Association proudly unveils, "The Profiles of LBD," a portrait series of families living with the disease. [More]
Infection with herpes simplex virus increases Alzheimer's risk

Infection with herpes simplex virus increases Alzheimer's risk

Infection with herpes simplex virus increases the risk of Alzheimer's disease. Researchers at Umeå University, Sweden, claim this in two studies in the journal Alzheimer's & Dementia. [More]
FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures. [More]
Researchers propose new milestones to augment National Alzheimer's Plan

Researchers propose new milestones to augment National Alzheimer's Plan

The U.S. Government has initiated a major effort to prevent and effectively treat Alzheimer's disease by 2025. However, a workgroup of nearly 40 Alzheimer's researchers and scientists says the research milestones in the U.S. Government's National Plan to Address Alzheimer's Disease must be broadened in scope, increased in scale, and adequately funded in order to successfully achieve this goal. [More]
Research: Ageing and depression are associated with epigenetic changes

Research: Ageing and depression are associated with epigenetic changes

Psychological stress and stress-related psychiatric disorders are associated with increased risk for aging-related diseases, but the molecular mechanisms underlying this relation are unknown. [More]
Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

In the nine years Parker has now served on the court, he has made the most of his opportunities. Child custody disputes, for instance, have made good occasions to expound on the role of religion in parental rights. [More]
Researchers discover new signaling pathway to fight excess body weight

Researchers discover new signaling pathway to fight excess body weight

The number of overweight persons is greatly increasing worldwide - and as a result is the risk of suffering a heart attack, stroke, diabetes or Alzheimer's disease. [More]
UCSF study: Smoking takes $18.1 billion toll in California

UCSF study: Smoking takes $18.1 billion toll in California

Smoking took an $18.1 billion toll in California – $487 for each resident – and was responsible for more than one in seven deaths in the state, more than from AIDS, influenza, diabetes or many other causes, according to the first comprehensive analysis in more than a decade on the financial and health impacts of tobacco. [More]
Middle-aged women with neurotic personality may develop Alzheimer disease later in life

Middle-aged women with neurotic personality may develop Alzheimer disease later in life

Women who worry, cope poorly with stress and/or experience mood swings in middle age run a higher risk of developing Alzheimer disease later in life. This is the conclusion of a study carried out at the Sahlgrenska Academy, University of Gothenburg, that followed 800 women for nearly 40 years. [More]
Penn State scientists find that mitochondrial disease more prevalent in older moms

Penn State scientists find that mitochondrial disease more prevalent in older moms

The discovery of a "maternal age effect" by a team of Penn State scientists that could be used to predict the accumulation of mitochondrial DNA mutations in maternal egg cells -- and the transmission of these mutations to children -- could provide valuable insights for genetic counseling. [More]
Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. [More]
New culture system confirms amyloid theory, can revolutionize drug discovery for Alzheimer's disease

New culture system confirms amyloid theory, can revolutionize drug discovery for Alzheimer's disease

An innovative laboratory culture system has succeeded, for the first time, in reproducing the full course of events underlying the development of Alzheimer's disease. [More]
Slug flow microextraction method for drug testing yields results in one minute

Slug flow microextraction method for drug testing yields results in one minute

A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement. [More]
USC to become a hub for exploring the human brain

USC to become a hub for exploring the human brain

In a rare distinction for one university, neuroimaging world leaders and USC Professors Arthur Toga and Paul Thompson will receive two major research center awards to advance their exploration of the human brain. [More]
CUMC researchers use innovative algorithm to find driving force behind aggressive form of glioblastoma

CUMC researchers use innovative algorithm to find driving force behind aggressive form of glioblastoma

Using an innovative algorithm that analyzes gene regulatory and signaling networks, Columbia University Medical Center researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer. [More]
UC Berkeley, UCSF researchers team up to create center for neurodegenerative disease research

UC Berkeley, UCSF researchers team up to create center for neurodegenerative disease research

Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases. Supported by a $3 million grant from the Glenn Foundation for Medical Research, the new center aims to pave the way to developing novel treatments for diseases such as Alzheimer's disease and Parkinson's disease by investigating the many ways that proteins can malfunction within cells. [More]
New findings link obesity and dietary factors to late-life dementias

New findings link obesity and dietary factors to late-life dementias

Difficulties learning, remembering, and concentrating. An inability to resist environmental temptations to eat. A lifetime of progressive deterioration in the brain. [More]
Researchers are developing compounds to combat causative agents of periodontitis

Researchers are developing compounds to combat causative agents of periodontitis

A total 12 million Germans suffer from periodontitis. If the inflammation remains untreated, this could lead to tooth loss. However, it is also suspected of triggering many other diseases, like cardiopulmonary diseases. Researchers are studying the interactions, and developing compounds to combat the causative agents. [More]
Women with healthy diet and lifestyle less likely to have stroke

Women with healthy diet and lifestyle less likely to have stroke

Women with a healthy diet and lifestyle may be less likely to have a stroke by more than half, according to a study published in the October 8, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]